a Vaccine against the coronavirus SARS-CoV-2 successfully tested on monkeys and hamsters. On the results of pre-clinical checks, said the head of the 48th Central research Institute of the Ministry of defense of the Russian Federation Sergey Borisevich. It is here together with the specialists of the National research centre of epidemiology and Microbiology named Gamalei led to the development of recombinant vaccines against COVID-19.
“During the animal studies proved the safety of the drug and its protective efficiency,” – said Borisevich in an interview with the newspaper “Red star”.
Previously, the defense Ministry reported that clinical trials have already selected 50 volunteers from the number of contract: this is a 45 men and 5 women aged from 25 to 50 years, healthy and without bad habits. Before the tests, they will be in isolation, before the start of the research pass the test for the coronavirus.
Testing for people will assess the safety and tolerability of the vaccine, and also understand how quickly after its introduction the body will begin to produce protective antibodies to a new type of coronavirus. It is planned that clinical trials of the vaccine will be completed before the end of July.
